Digital twins and AI are reducing clinical trial timelines from 10-15 years to 5-7 years while improving success rates. This guide covers the technology, FDA frameworks, key platforms, and implementation strategies for healthcare and biotech organizations.
AI-driven drug discovery is slashing traditional pharma timelines by 80%. With multiple AI-discovered drugs now in Phase II trials, the biotech investment landscape is being rewritten.